270 related articles for article (PubMed ID: 956340)
21. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R
Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722
[TBL] [Abstract][Full Text] [Related]
22. The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90.
Prince RL; Dick I; Devine A; Price RI; Gutteridge DH; Kerr D; Criddle A; Garcia-Webb P; St John A
J Bone Miner Res; 1995 Jun; 10(6):835-42. PubMed ID: 7572305
[TBL] [Abstract][Full Text] [Related]
23. [Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].
Esedova AE; Gadzhieva MM; Ferzilaeva RA
Klin Lab Diagn; 2002 Mar; (3):13-6. PubMed ID: 11980136
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
Christiansen C; Christensen MS; Larsen NE; Transbøl IB
J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
[TBL] [Abstract][Full Text] [Related]
25. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
26. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
Tsai KS; Ebeling PR; Riggs BL
J Clin Endocrinol Metab; 1989 Nov; 69(5):1024-7. PubMed ID: 2793989
[TBL] [Abstract][Full Text] [Related]
27. Calcium and salmon calcitonin in treatment of osteoporosis.
Jowsey J; Riggs BL; Kelly PJ; Hoffman DL
J Clin Endocrinol Metab; 1978 Sep; 47(3):633-9. PubMed ID: 263316
[TBL] [Abstract][Full Text] [Related]
28. Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Ishimura E; Miki T; Koyama H; Harada K; Nakatsuka K; Inaba M; Nishizawa Y; Morii H
Horm Metab Res; 1993 Sep; 25(9):493-7. PubMed ID: 8225204
[TBL] [Abstract][Full Text] [Related]
29. [Metabolism of calcium and phosphorus in Cushing syndrome with osteoporosis].
Meng XW; Liu SQ; Zhang KQ
Zhonghua Nei Ke Za Zhi; 1989 Sep; 28(9):548-52, 573. PubMed ID: 2627828
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid function in primary osteoporosis.
Riggs BL; Arnaud CD; Jowsey J; Goldsmith RS; Kelly PJ
J Clin Invest; 1973 Jan; 52(1):181-4. PubMed ID: 4734167
[TBL] [Abstract][Full Text] [Related]
31. Effects of oral therapy with calcium and vitamin D in primary osteoporosis.
Riggs BL; Jowsey J; Kelly PJ; Hoffman DL; Arnaud CD
J Clin Endocrinol Metab; 1976 Jun; 42(6):1139-44. PubMed ID: 932176
[TBL] [Abstract][Full Text] [Related]
32. Mineral and bone metabolism in thyroid disease: a review.
Auwerx J; Bouillon R
Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
[TBL] [Abstract][Full Text] [Related]
33. The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.
Celik E; Guzel S; Abali R; Guzelant AY; Celik Guzel E; Kuçukyalcin V
Minerva Med; 2013 Oct; 104(5):497-504. PubMed ID: 24101107
[TBL] [Abstract][Full Text] [Related]
34. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
[TBL] [Abstract][Full Text] [Related]
35. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
Pacifici R; McMurtry C; Vered I; Rupich R; Avioli LV
J Clin Endocrinol Metab; 1988 Apr; 66(4):747-53. PubMed ID: 3126214
[TBL] [Abstract][Full Text] [Related]
36. Laboratory aids in the diagnosis of metabolic bone disease.
Goldsmith RS
Orthop Clin North Am; 1972 Nov; 3(3):545-60. PubMed ID: 4344932
[No Abstract] [Full Text] [Related]
37. Juvenile osteoporosis: bone findings in seven patients.
Jowsey J; Johnson KA
J Pediatr; 1972 Sep; 81(3):511-7. PubMed ID: 5049819
[No Abstract] [Full Text] [Related]
38. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
39. Effects of a short course of estrogen on mineral metabolism in postmenopausal women.
Stock JL; Coderre JA; Mallette LE
J Clin Endocrinol Metab; 1985 Oct; 61(4):595-600. PubMed ID: 2993339
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
Charhon SA; Chapuy MC; Delvin EE; Meunier PJ
Miner Electrolyte Metab; 1985; 11(2):117-22. PubMed ID: 3838794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
